Dalim Thyssen Co., Ltd. (CEO Jong-seop Jeong and Hwan-gyu Jeong), a medical device and bio-collagen specialized company, announced that it has signed an exclusive distribution agreement for its flagship product, the gel-type hemostatic agent 'CollaStat', with global medical device company Corza Medical in Germany and Austria.
Collastat is a gel-type hemostatic agent with rapid hemostasis, easy handling, and high usability in surgical environments, enabling rapid hemostasis in various surgical situations.
Korza Medical is a global medical device company providing surgical biosurgery solutions to hospitals, distributors, and OEM partners worldwide. It boasts a robust global network in ophthalmology, wound closure, and biologic tissue engineering. This partnership will strengthen Darim Thyssen's position in the European market and provide synergy with Korza Medical's product portfolio.
A representative of Darimtissen stated, “The collaboration with Korza Medical is the result of recognition of the technological excellence and marketability of Collastat on the global stage,” and added, “We will continue to strive to develop high-quality biosurgery products and expand into overseas markets.”
- See more related articles
You must be logged in to post a comment.